Retrovirus-based mRNA transfer for transient cell manipulation

Methods in Molecular Biology

Volumn 969, Issue , 2013, Pages 139-161

  Galla, Melanie ^a   Schambach, Axel ^a   Baum, Christopher ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cell targeting; Dose controlled; Gammaretroviral vector; MRNA transfer; Murine leukemia virus; Non cytotoxic; RMT; Transient

Indexed keywords

MESSENGER RNA; TRANSPOSASE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CHEMISTRY; GENE DOSAGE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; GENETICS; METHODOLOGY; MOUSE; MURINE LEUKEMIA VIRUS; TRANSPOSON;

ANIMALS; DNA TRANSPOSABLE ELEMENTS; GENE DOSAGE; GENE EXPRESSION; LEUKEMIA VIRUS, MURINE; MICE; MUTAGENESIS, INSERTIONAL; RNA, MESSENGER; TRANSDUCTION, GENETIC; TRANSPOSASES;

MLCS; MLOWN;

EID: 84878659188     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-260-5_10     Document Type: Article

References (47)

1. Galla M, Will E, Kraunus J et al (2004) Retroviral pseudotransduction for targeted cell manipulation. Mol Cell 16:309-315
2. Galla M, Schambach A, Towers GJ, Baum C (2008) Cellular restriction of retrovirus particle-mediated mRNA transfer. J Virol 82:3069-3077
3. Galla M, Schambach A, Falk CS et al (2011) Avoiding cytotoxicity of transposases by dosecontrolled mRNA delivery. Nucleic Acids Res 39:7147-7160
4. Mann R, Mulligan RC, Baltimore D (1983) Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33:153-159
5. Hu WS, Temin HM (1990) Retroviral recombination and reverse transcription. Science 250:1227-1233
6. Lund AH, Duch M, Lovmand J et al (1997) Complementation of a primer binding siteimpaired murine leukemia virus-derived retroviral vector by a genetically engineered tRNA-like primer. J Virol 71:1191-1195
7. Hildinger M, Abel KL, Ostertag W, Baum C (1999) Design of 5 ¢ untranslated sequences in retroviral vectors developed for medical use. J Virol 73:4083-4089
8. Schambach A, Mueller D, Galla M et al (2006) Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors. Gene Ther 13:1524-1533
9. Hope T (2002) Improving the post-transcriptional aspects of lentiviral vectors. Curr Top Microbiol Immunol 261:179-189
10. Schambach A, Galla M, Maetzig T et al (2007) Improving transcriptional termination of selfinactivating gamma-retroviral and lentiviral vectors. Mol Ther 15:1167-1173
11. Higashimoto T, Urbinati F, Perumbeti A et al (2007) The woodchuck hepatitis virus posttranscriptional regulatory element reduces readthrough transcription from retroviral vectors. Gene Ther 14:1298-1304
12. Schambach A, Bohne J, Baum C et al (2006) Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression. Gene Ther 13:641-645
13. Schambach A, Swaney WP, van der Loo JC (2009) Design and production of retro-and lentiviral vectors for gene expression in hematopoietic cells. Methods Mol Biol 506: 191-205
14. Buchholz CJ, Muhlebach MD, Cichutek K (2009) Lentiviral vectors with measles virus glycoproteins -dream team for gene transfer? Trends Biotechnol 27:259-265
15. Voelkel C, Galla M, Maetzig T et al (2010) Protein transduction from retroviral Gag precursors. Proc Natl Acad Sci USA 107: 7805-7810
16. Schambach A, Bohne J, Chandra S et al (2006) Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells. Mol Ther 13:391-400
17. Yang Y, Vanin EF, Whitt MA et al (1995) Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein. Hum Gene Ther 6:1203-1213
18. Raymond CS, Soriano P (2007) Highef ficiency FLP and PhiC31 site-speci fic recombination in mammalian cells. PLoS One 2:e162
19. Kozak M (1987) An analysis of 5 ¢ -noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 15:8125-8148
20. Donello JE, Loeb JE, Hope TJ (1998) Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J Virol 72:5085-5092
21. Zufferey R, Donello JE, Trono D, Hope ZJ (1999) Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 73:2886-2892
22. Popa I, Harris ME, Donello JE, Hope TJ (2002) CRM1-dependent function of a cisacting RNA export element. Mol Cell Biol 22:2057-2067
23. Morita S, Kojima T, Kitamura T (2000) Plat-E: an ef ficient and stable system for transient packaging of retroviruses. Gene Ther 7: 1063-1070
24. Sandrin V, Boson B, Salmon P et al (2002) Lentiviral vectors pseudotyped with a modi fied RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates. Blood 100:823-832
25. Kwon YJ, Hung G, Anderson WF et al (2003) Determination of infectious retrovirus concentration from colony-forming assay with quantitative analysis. J Virol 77:5712-5720
26. Beyer WR, Westphal M, Ostertag W, von Laer D (2002) Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range. J Virol 76:1488-1495
27. Berkowitz R, Fisher J, Goff SP (1996) RNA packaging. Curr Top Microbiol Immunol 214:177-218
28. Rulli SJ Jr, Hibbert CS, Mirro J et al (2007) Selective and nonselective packaging of cellular RNAs in retrovirus particles. J Virol 81:6623-6631
29. Muriaux D, Mirro J, Harvin D, Rein A (2001) RNA is a structural element in retrovirus particles. Proc Natl Acad Sci USA 98:5246-5251
30. Toyoshima K, Vogt PK (1969) Enhancement and inhibition of avian sarcoma viruses by polycations and polyanions. Virology 38: 414-426
31. Hennemann B, Chuo JY, Schley PD, Lambie K et al (2000) High-ef ficiency retroviral transduction of mammalian cells on positively charged surfaces. Hum Gene Ther 11:43-51
32. Ho WZ, Cherukuri R, Ge SD et al (1993) Centrifugal enhancement of human immunode ficiency virus type 1 infection and human cytomegalovirus gene expression in human primary monocyte/macrophages in vitro. J Leukoc Biol 53:208-212
33. Bahnson AB, Dunigan JT, Baysal BE et al (1995) Centrifugal enhancement of retroviral mediated gene transfer. J Virol Methods 54:131-143
34. Kotani H, Newton PB 3rd, Zhang S et al (1994) Improved methods of retroviral vector transduction and production for gene therapy. Hum Gene Ther 5:19-28
35. Hodgkin PD, Scalzo AA, Swaminathan N et al (1988) Murine cytomegalovirus binds reversibly to mouse embryo fibroblasts: implications for quantitation and explanation of centrifugal enhancement. J Virol Methods 22:215-230
36. Guo J, Wang W, Yu D, Wu Y (2011) Spinoculation triggers dynamic actin and co filin activity that facilitates HIV-1 infection of transformed and resting CD4 T cells. J Virol 85:9824-9833
37. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408
38. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:1101-1108
39. Schmittgen TD, Zakrajsek BA, Mills AG et al (2000) Quantitative reverse transcriptionpolymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal Biochem 285:194-204
40. Modlich U, Schambach A, Li Z, Schiedlmeier B (2009) Murine hematopoietic stem cell transduction using retroviral vectors. Methods Mol Biol 506:23-31
41. Ruoslahti E (1988) Fibronectin and its receptors. Ann Rev Biochem 57:375-413
42. Kimizuka F, Taguchi Y, Ohdate Y et al (1991) Production and characterization of functional domains of human fibronectin expressed in Escherichia coli. J Biochem 110:284-291
43. Hanenberg H, Hashino K, Konishi H et al (1997) Optimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoietic cells. Hum Gene Ther 8: 2193-2206
44. Asada K, Uemori T, Ueno T et al (1998) Enhancement of retroviral gene transduction on a dish coated with a cocktail of two different polypeptides: one exhibiting binding activity toward target cells, and the other toward retroviral vectors. J Biochem 123: 1041-1047
45. van der Loo JC, Xiao X, McMillin D et al (1998) VLA-5 is expressed by mouse and human long-term repopulating hematopoietic cells and mediates adhesion to extracellular matrix protein fibronectin. J Clin Invest 102:1051-1061
46. Hanenberg H, Xiao XL, Dilloo D et al (1996) Colocalization of retrovirus and target cells on speci fic fibronectin fragments increases genetic transduction of mammalian cells. Nat Med 2:876-882
47. Grez M, Akgun E, Hilberg F, Ostertag W (1990) Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells. Proc Natl Acad Sci USA 87:9202-9206